Clinicial utility of biochemical markers

Osteoporosis International

Volumn 9, Issue SUPPL. 2, 1999, Pages

  Lindsay, Robert ^a,b  

^a HELEN HAYES HOSPITAL   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CHOLESTEROL; OSTEOCALCIN; PROCOLLAGEN;

ALKALINE PHOSPHATASE BLOOD LEVEL; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE REMODELING; BONE TURNOVER; CONFERENCE PAPER; CONTROLLED STUDY; FRACTURE; HUMAN; HUMAN TISSUE; OSTEOPOROSIS; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; HUMANS; OSTEOPOROSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0032922367     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00004158     Document Type: Conference Paper

References (16)

1. Blumsohn A, Eastell R. The performance and utility of biochemical markers of bone turnover: do we know enough to use them in clinical practice? Ann Clin Biochem 1997;34:449-59.
2. Looker AC, Bauer DC, Chestnut CH, Gundberg CM, Hochberg MC, Klee G, Kleerekoper M, Watts NB, Bell NH. Clinical use of biochemical markers of bone remodeling: current status and future direction. A report of the NOF (submitted).
3. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 1996;11:1531-38.
4. van Daele PLA, Seibel MJ, Burger H, et al. Case-control analysis of bone resporption markers, disability, and hip fracture risk: the Rotterdam study. BMJ 1996;312:482-3.
5. Akesson K, Ljunghall S, Jonsson B, Sernbo I, Johnell O, Gardsell P, Obrant KJ. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women. J Bone Miner Res 1995;10:1823-9.
6. Garnero P, Dargent-Molina P, Hans D, Schott AM, Breart G, Meunier PJ, Delmas PD. Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurements for the prediction of hip fracture in elderly women? The EPIDOS prospective study. Osteoporos Int 1998;8:563-9.
7. Ross PD, Wasnich RD, Knowlton WK. Skeletal alkaline phosphatase (Tandem©-R Ostase©) measurements predict vertebral fractures: a prospective study. (Abstract). J Bone Miner Res 1997;12 (Suppl 1):S150.
8. Cosman F, Nieves J, Wilkinson C, Schnering D, Shen V, Lindsay R. Bone density change and biochemical indices of skeletal turnover. Calcif Tissue Int 1996;58:236-43.
9. Keen RW, Nguyen T, Sobnack R, Perry LA, Thompson PW, Spector TD. Can biochemical markers predict bone loss at the hip and spine?: a 4-year prospective study of 141 early postmenopausal women. Osteoporos Int 1996;6:399-406.
10. Ross PD, Knowlton W. Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 1997;13:297-302.
11. Hesley RP, Shepard KA, Jenkins DK, Riggs BL. Monitoring estrogen replacement therapy and identifying rapid bone losers with an immunoassay for deoxypyridinoline. Osteoporos Int 1998;8:159-64.
12. Garnero P, Haausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 1996;11:1531-8.
13. Chesnut C, Bell NH, Clark GS, et al. Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med 1997;102:29-37.
14. Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J Bone Miner Res 1998;13:1431-1438.
15. Marcus R, Holloway L, Wells B. Turnover markers only weakly predict bone response to estrogen: The postmenopausal estrogen-progestin interventions Trial (PEPI) (abstract). J Bone Mienr Res 1997;12 (suppl 1):S103.
16. Chen J, Hosoda K, Hasumi K, Ogata E, Shiraki M. Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women. J Bone Miner Res 1996;11:1784-92.